Efficacy and Safety Study of GerEPO

NCT00229099 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

270

Enrollment

OTHER_GOV

Sponsor class

Conditions

Chronic Renal Failure Related Anemia

Interventions

DRUG: GerEPO

Sponsor

Ministry of Health, Malaysia